Gene therapy (gene therapy) refers to the introduction of foreign normal genes into target cells to correct or compensate for diseases caused by defects and abnormal genes in order to achieve therapeutic purposes. It also includes the application of technology such as transgenes, that is, inserting foreign genes into appropriate recipient cells of patients through gene transfer technology, so that the products made by foreign genes can treat certain diseases. Broadly speaking, gene therapy can also include measures and new technologies taken from the DNA level to treat certain diseases. Cell therapy is a brand-new drug development model. In this type of therapy, immune cell therapy has proved to have the most potential. Now researchers have demonstrated its clinical benefits in the treatment of cancer and infectious diseases, and these There are many different characteristics between therapy and traditional therapy, including its ability to expand and contract as needed, and to adjust the therapeutic effect of the body within a few months or years after a single application; due to basic immunology, gene function, gene editing With the continuous application and progress of synthetic biology, the complexity of immune cell therapy has been greatly expanded, which can improve the effectiveness and safety of immune cell therapy, and also increase its potential for treating diseases.
This report aims to provide a comprehensive presentation of the global market for Cell and Gene Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell and Gene Therapy. This report contains market size and forecasts of Cell and Gene Therapy in global, including the following market information:
Global Cell and Gene Therapy Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Cell and Gene Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Rare Diseases Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cell and Gene Therapy include Amgen Inc., bluebird bio, Inc., Dendreon Pharmaceuticals LLC., Fibrocell Science, Inc., Human Stem Cells Institute, Kite Pharma, Inc., Kolon TissueGene, Inc., Novartis AG and Orchard Therapeutics plc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Cell and Gene Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cell and Gene Therapy Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Cell and Gene Therapy Market Segment Percentages, by Type, 2022 (%)
Rare Diseases
Oncology
Hematology
Cardiovascular
Ophthalmology
Neurology
Other Therapeutic Classes
Global Cell and Gene Therapy Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Cell and Gene Therapy Market Segment Percentages, by Application, 2022 (%)
Pharmaceutical and Biotechnology Companies
Research and Academic Institutions
Contract Research Organizations (CROs)
Hospital
Others
Global Cell and Gene Therapy Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Cell and Gene Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cell and Gene Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cell and Gene Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen Inc.
bluebird bio, Inc.
Dendreon Pharmaceuticals LLC.
Fibrocell Science, Inc.
Human Stem Cells Institute
Kite Pharma, Inc.
Kolon TissueGene, Inc.
Novartis AG
Orchard Therapeutics plc.
Organogenesis Holdings Inc.
Pfizer, Inc.
RENOVA THERAPEUTICS
Shanghai Sunway Biotech Co., Ltd.,
Sibiono GeneTech Co. Ltd.,
Spark Therapeutics, Inc.
Vericel Corporation
ViroMed Co., Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cell and Gene Therapy, market overview.
Chapter 2: Global Cell and Gene Therapy market size in revenue.
Chapter 3: Detailed analysis of Cell and Gene Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cell and Gene Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cell and Gene Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cell and Gene Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cell and Gene Therapy Overall Market Size
2.1 Global Cell and Gene Therapy Market Size: 2022 VS 2030
2.2 Global Cell and Gene Therapy Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cell and Gene Therapy Players in Global Market
3.2 Top Global Cell and Gene Therapy Companies Ranked by Revenue
3.3 Global Cell and Gene Therapy Revenue by Companies
3.4 Top 3 and Top 5 Cell and Gene Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cell and Gene Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cell and Gene Therapy Players in Global Market
3.6.1 List of Global Tier 1 Cell and Gene Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Cell and Gene Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cell and Gene Therapy Market Size Markets, 2022 & 2030
4.1.2 Rare Diseases
4.1.3 Oncology
4.1.4 Hematology
4.1.5 Cardiovascular
4.1.6 Ophthalmology
4.1.7 Neurology
4.1.8 Other Therapeutic Classes
4.2 By Type - Global Cell and Gene Therapy Revenue & Forecasts
4.2.1 By Type - Global Cell and Gene Therapy Revenue, 2018-2023
4.2.2 By Type - Global Cell and Gene Therapy Revenue, 2024-2030
4.2.3 By Type - Global Cell and Gene Therapy Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cell and Gene Therapy Market Size, 2022 & 2030
5.1.2 Pharmaceutical and Biotechnology Companies
5.1.3 Research and Academic Institutions
5.1.4 Contract Research Organizations (CROs)
5.1.5 Hospital
5.1.6 Others
5.2 By Application - Global Cell and Gene Therapy Revenue & Forecasts
5.2.1 By Application - Global Cell and Gene Therapy Revenue, 2018-2023
5.2.2 By Application - Global Cell and Gene Therapy Revenue, 2024-2030
5.2.3 By Application - Global Cell and Gene Therapy Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Cell and Gene Therapy Market Size, 2022 & 2030
6.2 By Region - Global Cell and Gene Therapy Revenue & Forecasts
6.2.1 By Region - Global Cell and Gene Therapy Revenue, 2018-2023
6.2.2 By Region - Global Cell and Gene Therapy Revenue, 2024-2030
6.2.3 By Region - Global Cell and Gene Therapy Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Cell and Gene Therapy Revenue, 2018-2030
6.3.2 US Cell and Gene Therapy Market Size, 2018-2030
6.3.3 Canada Cell and Gene Therapy Market Size, 2018-2030
6.3.4 Mexico Cell and Gene Therapy Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Cell and Gene Therapy Revenue, 2018-2030
6.4.2 Germany Cell and Gene Therapy Market Size, 2018-2030
6.4.3 France Cell and Gene Therapy Market Size, 2018-2030
6.4.4 U.K. Cell and Gene Therapy Market Size, 2018-2030
6.4.5 Italy Cell and Gene Therapy Market Size, 2018-2030
6.4.6 Russia Cell and Gene Therapy Market Size, 2018-2030
6.4.7 Nordic Countries Cell and Gene Therapy Market Size, 2018-2030
6.4.8 Benelux Cell and Gene Therapy Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Cell and Gene Therapy Revenue, 2018-2030
6.5.2 China Cell and Gene Therapy Market Size, 2018-2030
6.5.3 Japan Cell and Gene Therapy Market Size, 2018-2030
6.5.4 South Korea Cell and Gene Therapy Market Size, 2018-2030
6.5.5 Southeast Asia Cell and Gene Therapy Market Size, 2018-2030
6.5.6 India Cell and Gene Therapy Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Cell and Gene Therapy Revenue, 2018-2030
6.6.2 Brazil Cell and Gene Therapy Market Size, 2018-2030
6.6.3 Argentina Cell and Gene Therapy Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cell and Gene Therapy Revenue, 2018-2030
6.7.2 Turkey Cell and Gene Therapy Market Size, 2018-2030
6.7.3 Israel Cell and Gene Therapy Market Size, 2018-2030
6.7.4 Saudi Arabia Cell and Gene Therapy Market Size, 2018-2030
6.7.5 UAE Cell and Gene Therapy Market Size, 2018-2030
7 Cell and Gene Therapy Companies Profiles
7.1 Amgen Inc.
7.1.1 Amgen Inc. Company Summary
7.1.2 Amgen Inc. Business Overview
7.1.3 Amgen Inc. Cell and Gene Therapy Major Product Offerings
7.1.4 Amgen Inc. Cell and Gene Therapy Revenue in Global Market (2018-2023)
7.1.5 Amgen Inc. Key News & Latest Developments
7.2 bluebird bio, Inc.
7.2.1 bluebird bio, Inc. Company Summary
7.2.2 bluebird bio, Inc. Business Overview
7.2.3 bluebird bio, Inc. Cell and Gene Therapy Major Product Offerings
7.2.4 bluebird bio, Inc. Cell and Gene Therapy Revenue in Global Market (2018-2023)
7.2.5 bluebird bio, Inc. Key News & Latest Developments
7.3 Dendreon Pharmaceuticals LLC.
7.3.1 Dendreon Pharmaceuticals LLC. Company Summary
7.3.2 Dendreon Pharmaceuticals LLC. Business Overview
7.3.3 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Major Product Offerings
7.3.4 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Revenue in Global Market (2018-2023)
7.3.5 Dendreon Pharmaceuticals LLC. Key News & Latest Developments
7.4 Fibrocell Science, Inc.
7.4.1 Fibrocell Science, Inc. Company Summary
7.4.2 Fibrocell Science, Inc. Business Overview
7.4.3 Fibrocell Science, Inc. Cell and Gene Therapy Major Product Offerings
7.4.4 Fibrocell Science, Inc. Cell and Gene Therapy Revenue in Global Market (2018-2023)
7.4.5 Fibrocell Science, Inc. Key News & Latest Developments
7.5 Human Stem Cells Institute
7.5.1 Human Stem Cells Institute Company Summary
7.5.2 Human Stem Cells Institute Business Overview
7.5.3 Human Stem Cells Institute Cell and Gene Therapy Major Product Offerings
7.5.4 Human Stem Cells Institute Cell and Gene Therapy Revenue in Global Market (2018-2023)
7.5.5 Human Stem Cells Institute Key News & Latest Developments
7.6 Kite Pharma, Inc.
7.6.1 Kite Pharma, Inc. Company Summary
7.6.2 Kite Pharma, Inc. Business Overview
7.6.3 Kite Pharma, Inc. Cell and Gene Therapy Major Product Offerings
7.6.4 Kite Pharma, Inc. Cell and Gene Therapy Revenue in Global Market (2018-2023)
7.6.5 Kite Pharma, Inc. Key News & Latest Developments
7.7 Kolon TissueGene, Inc.
7.7.1 Kolon TissueGene, Inc. Company Summary
7.7.2 Kolon TissueGene, Inc. Business Overview
7.7.3 Kolon TissueGene, Inc. Cell and Gene Therapy Major Product Offerings
7.7.4 Kolon TissueGene, Inc. Cell and Gene Therapy Revenue in Global Market (2018-2023)
7.7.5 Kolon TissueGene, Inc. Key News & Latest Developments
7.8 Novartis AG
7.8.1 Novartis AG Company Summary
7.8.2 Novartis AG Business Overview
7.8.3 Novartis AG Cell and Gene Therapy Major Product Offerings
7.8.4 Novartis AG Cell and Gene Therapy Revenue in Global Market (2018-2023)
7.8.5 Novartis AG Key News & Latest Developments
7.9 Orchard Therapeutics plc.
7.9.1 Orchard Therapeutics plc. Company Summary
7.9.2 Orchard Therapeutics plc. Business Overview
7.9.3 Orchard Therapeutics plc. Cell and Gene Therapy Major Product Offerings
7.9.4 Orchard Therapeutics plc. Cell and Gene Therapy Revenue in Global Market (2018-2023)
7.9.5 Orchard Therapeutics plc. Key News & Latest Developments
7.10 Organogenesis Holdings Inc.
7.10.1 Organogenesis Holdings Inc. Company Summary
7.10.2 Organogenesis Holdings Inc. Business Overview
7.10.3 Organogenesis Holdings Inc. Cell and Gene Therapy Major Product Offerings
7.10.4 Organogenesis Holdings Inc. Cell and Gene Therapy Revenue in Global Market (2018-2023)
7.10.5 Organogenesis Holdings Inc. Key News & Latest Developments
7.11 Pfizer, Inc.
7.11.1 Pfizer, Inc. Company Summary
7.11.2 Pfizer, Inc. Business Overview
7.11.3 Pfizer, Inc. Cell and Gene Therapy Major Product Offerings
7.11.4 Pfizer, Inc. Cell and Gene Therapy Revenue in Global Market (2018-2023)
7.11.5 Pfizer, Inc. Key News & Latest Developments
7.12 RENOVA THERAPEUTICS
7.12.1 RENOVA THERAPEUTICS Company Summary
7.12.2 RENOVA THERAPEUTICS Business Overview
7.12.3 RENOVA THERAPEUTICS Cell and Gene Therapy Major Product Offerings
7.12.4 RENOVA THERAPEUTICS Cell and Gene Therapy Revenue in Global Market (2018-2023)
7.12.5 RENOVA THERAPEUTICS Key News & Latest Developments
7.13 Shanghai Sunway Biotech Co., Ltd.,
7.13.1 Shanghai Sunway Biotech Co., Ltd., Company Summary
7.13.2 Shanghai Sunway Biotech Co., Ltd., Business Overview
7.13.3 Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Major Product Offerings
7.13.4 Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Revenue in Global Market (2018-2023)
7.13.5 Shanghai Sunway Biotech Co., Ltd., Key News & Latest Developments
7.14 Sibiono GeneTech Co. Ltd.,
7.14.1 Sibiono GeneTech Co. Ltd., Company Summary
7.14.2 Sibiono GeneTech Co. Ltd., Business Overview
7.14.3 Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Major Product Offerings
7.14.4 Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Revenue in Global Market (2018-2023)
7.14.5 Sibiono GeneTech Co. Ltd., Key News & Latest Developments
7.15 Spark Therapeutics, Inc.
7.15.1 Spark Therapeutics, Inc. Company Summary
7.15.2 Spark Therapeutics, Inc. Business Overview
7.15.3 Spark Therapeutics, Inc. Cell and Gene Therapy Major Product Offerings
7.15.4 Spark Therapeutics, Inc. Cell and Gene Therapy Revenue in Global Market (2018-2023)
7.15.5 Spark Therapeutics, Inc. Key News & Latest Developments
7.16 Vericel Corporation
7.16.1 Vericel Corporation Company Summary
7.16.2 Vericel Corporation Business Overview
7.16.3 Vericel Corporation Cell and Gene Therapy Major Product Offerings
7.16.4 Vericel Corporation Cell and Gene Therapy Revenue in Global Market (2018-2023)
7.16.5 Vericel Corporation Key News & Latest Developments
7.17 ViroMed Co., Ltd.
7.17.1 ViroMed Co., Ltd. Company Summary
7.17.2 ViroMed Co., Ltd. Business Overview
7.17.3 ViroMed Co., Ltd. Cell and Gene Therapy Major Product Offerings
7.17.4 ViroMed Co., Ltd. Cell and Gene Therapy Revenue in Global Market (2018-2023)
7.17.5 ViroMed Co., Ltd. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cell and Gene Therapy Market Opportunities & Trends in Global Market
Table 2. Cell and Gene Therapy Market Drivers in Global Market
Table 3. Cell and Gene Therapy Market Restraints in Global Market
Table 4. Key Players of Cell and Gene Therapy in Global Market
Table 5. Top Cell and Gene Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cell and Gene Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cell and Gene Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cell and Gene Therapy Product Type
Table 9. List of Global Tier 1 Cell and Gene Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cell and Gene Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cell and Gene Therapy Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Cell and Gene Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cell and Gene Therapy Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Cell and Gene Therapy Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Cell and Gene Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cell and Gene Therapy Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Cell and Gene Therapy Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Cell and Gene Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cell and Gene Therapy Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Cell and Gene Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cell and Gene Therapy Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Cell and Gene Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cell and Gene Therapy Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Cell and Gene Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cell and Gene Therapy Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Cell and Gene Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cell and Gene Therapy Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Cell and Gene Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cell and Gene Therapy Revenue, (US$, Mn), 2024-2030
Table 30. Amgen Inc. Company Summary
Table 31. Amgen Inc. Cell and Gene Therapy Product Offerings
Table 32. Amgen Inc. Cell and Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Amgen Inc. Key News & Latest Developments
Table 34. bluebird bio, Inc. Company Summary
Table 35. bluebird bio, Inc. Cell and Gene Therapy Product Offerings
Table 36. bluebird bio, Inc. Cell and Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. bluebird bio, Inc. Key News & Latest Developments
Table 38. Dendreon Pharmaceuticals LLC. Company Summary
Table 39. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Product Offerings
Table 40. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Dendreon Pharmaceuticals LLC. Key News & Latest Developments
Table 42. Fibrocell Science, Inc. Company Summary
Table 43. Fibrocell Science, Inc. Cell and Gene Therapy Product Offerings
Table 44. Fibrocell Science, Inc. Cell and Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Fibrocell Science, Inc. Key News & Latest Developments
Table 46. Human Stem Cells Institute Company Summary
Table 47. Human Stem Cells Institute Cell and Gene Therapy Product Offerings
Table 48. Human Stem Cells Institute Cell and Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Human Stem Cells Institute Key News & Latest Developments
Table 50. Kite Pharma, Inc. Company Summary
Table 51. Kite Pharma, Inc. Cell and Gene Therapy Product Offerings
Table 52. Kite Pharma, Inc. Cell and Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Kite Pharma, Inc. Key News & Latest Developments
Table 54. Kolon TissueGene, Inc. Company Summary
Table 55. Kolon TissueGene, Inc. Cell and Gene Therapy Product Offerings
Table 56. Kolon TissueGene, Inc. Cell and Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Kolon TissueGene, Inc. Key News & Latest Developments
Table 58. Novartis AG Company Summary
Table 59. Novartis AG Cell and Gene Therapy Product Offerings
Table 60. Novartis AG Cell and Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Novartis AG Key News & Latest Developments
Table 62. Orchard Therapeutics plc. Company Summary
Table 63. Orchard Therapeutics plc. Cell and Gene Therapy Product Offerings
Table 64. Orchard Therapeutics plc. Cell and Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. Orchard Therapeutics plc. Key News & Latest Developments
Table 66. Organogenesis Holdings Inc. Company Summary
Table 67. Organogenesis Holdings Inc. Cell and Gene Therapy Product Offerings
Table 68. Organogenesis Holdings Inc. Cell and Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. Organogenesis Holdings Inc. Key News & Latest Developments
Table 70. Pfizer, Inc. Company Summary
Table 71. Pfizer, Inc. Cell and Gene Therapy Product Offerings
Table 72. Pfizer, Inc. Cell and Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 73. Pfizer, Inc. Key News & Latest Developments
Table 74. RENOVA THERAPEUTICS Company Summary
Table 75. RENOVA THERAPEUTICS Cell and Gene Therapy Product Offerings
Table 76. RENOVA THERAPEUTICS Cell and Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 77. RENOVA THERAPEUTICS Key News & Latest Developments
Table 78. Shanghai Sunway Biotech Co., Ltd., Company Summary
Table 79. Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Product Offerings
Table 80. Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 81. Shanghai Sunway Biotech Co., Ltd., Key News & Latest Developments
Table 82. Sibiono GeneTech Co. Ltd., Company Summary
Table 83. Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Product Offerings
Table 84. Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 85. Sibiono GeneTech Co. Ltd., Key News & Latest Developments
Table 86. Spark Therapeutics, Inc. Company Summary
Table 87. Spark Therapeutics, Inc. Cell and Gene Therapy Product Offerings
Table 88. Spark Therapeutics, Inc. Cell and Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 89. Spark Therapeutics, Inc. Key News & Latest Developments
Table 90. Vericel Corporation Company Summary
Table 91. Vericel Corporation Cell and Gene Therapy Product Offerings
Table 92. Vericel Corporation Cell and Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 93. Vericel Corporation Key News & Latest Developments
Table 94. ViroMed Co., Ltd. Company Summary
Table 95. ViroMed Co., Ltd. Cell and Gene Therapy Product Offerings
Table 96. ViroMed Co., Ltd. Cell and Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 97. ViroMed Co., Ltd. Key News & Latest Developments
List of Figures
Figure 1. Cell and Gene Therapy Segment by Type in 2022
Figure 2. Cell and Gene Therapy Segment by Application in 2022
Figure 3. Global Cell and Gene Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cell and Gene Therapy Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Cell and Gene Therapy Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cell and Gene Therapy Revenue in 2022
Figure 8. By Type - Global Cell and Gene Therapy Revenue Market Share, 2018-2030
Figure 9. By Application - Global Cell and Gene Therapy Revenue Market Share, 2018-2030
Figure 10. By Type - Global Cell and Gene Therapy Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Cell and Gene Therapy Revenue Market Share, 2018-2030
Figure 12. By Application - Global Cell and Gene Therapy Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Cell and Gene Therapy Revenue Market Share, 2018-2030
Figure 14. By Region - Global Cell and Gene Therapy Revenue Market Share, 2018-2030
Figure 15. By Country - North America Cell and Gene Therapy Revenue Market Share, 2018-2030
Figure 16. US Cell and Gene Therapy Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Cell and Gene Therapy Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Cell and Gene Therapy Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Cell and Gene Therapy Revenue Market Share, 2018-2030
Figure 20. Germany Cell and Gene Therapy Revenue, (US$, Mn), 2018-2030
Figure 21. France Cell and Gene Therapy Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Cell and Gene Therapy Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Cell and Gene Therapy Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Cell and Gene Therapy Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Cell and Gene Therapy Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Cell and Gene Therapy Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Cell and Gene Therapy Revenue Market Share, 2018-2030
Figure 28. China Cell and Gene Therapy Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Cell and Gene Therapy Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Cell and Gene Therapy Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Cell and Gene Therapy Revenue, (US$, Mn), 2018-2030
Figure 32. India Cell and Gene Therapy Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Cell and Gene Therapy Revenue Market Share, 2018-2030
Figure 34. Brazil Cell and Gene Therapy Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Cell and Gene Therapy Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Cell and Gene Therapy Revenue Market Share, 2018-2030
Figure 37. Turkey Cell and Gene Therapy Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Cell and Gene Therapy Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Cell and Gene Therapy Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Cell and Gene Therapy Revenue, (US$, Mn), 2018-2030
Figure 41. Amgen Inc. Cell and Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. bluebird bio, Inc. Cell and Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Fibrocell Science, Inc. Cell and Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Human Stem Cells Institute Cell and Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Kite Pharma, Inc. Cell and Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Kolon TissueGene, Inc. Cell and Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Novartis AG Cell and Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Orchard Therapeutics plc. Cell and Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Organogenesis Holdings Inc. Cell and Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Pfizer, Inc. Cell and Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. RENOVA THERAPEUTICS Cell and Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Spark Therapeutics, Inc. Cell and Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Vericel Corporation Cell and Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. ViroMed Co., Ltd. Cell and Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
